Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 619 of 6351
-
Can a new pill ease postpartum depression? a Real-World study investigates
Disease control CompletedIn this study, researchers will learn more about how zuranolone affects the symptoms of postpartum depression, also known as PPD. Zuranolone is a drug that healthcare professionals can prescribe for adults with PPD. After giving birth, adults with PPD can suffer from symptoms suc…
Sponsor: Biogen • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New heart drug aficamten shows promise for japanese patients with thick heart muscle
Disease control OngoingResearchers are looking for a better way to treat Japanese people who have symptomatic obstructive hypertrophic cardiomyopathy (symptomatic oHCM). Obstructive hypertrophic cardiomyopathy (oHCM) is a type of heart disease where the heart muscles become thicker than normal due to …
Phase 3 • Sponsor: Bayer • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New drug shows promise for Hard-to-Treat breast cancer
Disease control OngoingThe purpose of this clinical study is to learn about the safety and effects of the study medicine (called disitamab vedotin) for the possible treatment of people with breast cancer that is hard to treat and has spread in the body (advanced cancer). This study is seeking particip…
Phase 1/2 • Sponsor: Pfizer • Aim: Disease control
Last updated Sep 10, 2026 02:00 UTC
-
Ancient Bone-Setting vs. modern surgery: which heals shoulder fractures better?
Disease control CompletedThe goal of this study was to compare Traditional Mongolian Medicine (TMM) bone-setting with open reduction and internal fixation (ORIF) surgery for adults with humeral surgical neck fracture. The study examined whether the two treatment approaches were associated with different …
Sponsor: Mongolian National University of Medical Sciences • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Can a smart insulin pump outsmart pizza? a trial puts it to the test
Disease control CompletedThe aim of this interventional clinical study is to compare the postprandial glycemic profile of patients with type 1 diabetes using either an open-loop (Medtronic Minimed 640G) or closed-loop (Medtronic Minimed 780G) insulin pump, after consuming a high-fat meal (pizza). The new…
Sponsor: Konstantinos Makrilakis, MD • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Promising new pill for rare childhood brain diseases enters final testing
Disease control OngoingAn 18-month double-blind, randomized, placebo-controlled, multicenter, Phase 3 study to evaluate the safety and efficacy of oral nizubaglustat (AZ-3102) in late-infantile and juvenile forms of GM1 gangliosidosis or GM2 gangliosidosis
Phase 3 • Sponsor: Azafaros B.V. • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New hope for myeloma: experimental drug etentamig enters human trials
Disease control Recruiting nowMultiple myeloma (MM) is a cancer of the blood's plasma cells. The cancer is typically found in the bones and bone marrow (the spongy tissue inside of the bones) and can cause bone pain, fractures, infections, weaker bones, and kidney failure. Treatments are available, but MM can…
Phase 1/2 • Sponsor: AbbVie • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Could immune cells fight Alzheimer's? new study tests Long-Term safety
Disease control Recruiting nowOpen-Label Extension Protocol to SNK01-AD01 Study
Phase 2 • Sponsor: NKGen Biotech, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Boron therapy takes aim at deadly brain tumors
Disease control Recruiting nowThis Phase I/II study, titled 'A Phase I/II Study to Evaluate Safety and Efficacy of the Boron Neutron Capture Therapy (BNCT) using B10 L-BPA as Boron Carrier in Malignant Brain Tumors.', aims to assess the efficacy of B10 L-BPA with BNCT in patients with malignant brain tumors. …
Phase 1/2 • Sponsor: China Medical University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New combo therapy aims to control brain tumors in lung cancer patients
Disease control Recruiting nowFor non-small cell lung cancer brain metastases, stereotactic radiotherapy is gradually replacing whole brain radiotherapy as the standard treatment. When patients have multiple brain metastases or larger tumors (diameter\>2cm), single session stereotactic radiotherapy (SRS) may …
Phase 3 • Sponsor: Sun Yat-Sen University Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New family program aims to prevent multiple health crises in latino immigrant communities
Prevention Recruiting nowThis study aims to prevent syndemic health conditions by decreasing acculturative stress and promoting resilience via SER Familia (Salud, Estrés y Resilencia en Familias/ Health, Stress, and Resilience in Families), a family-based intervention. SER Familia is a six-session interv…
Sponsor: Duke University • Aim: Prevention
Last updated Jun 27, 2026 12:05 UTC
-
New weekly shot aims to tame Sjögren's Flare-Ups
Disease control Recruiting nowThis is a Phase 2b, multicenter, randomized, double-blinded, placebo-controlled study to assess the efficacy and safety of IMVT-1402 in adult participants with moderate to severe systemic primary Sjogren's disease (SjD).
Phase 2 • Sponsor: Immunovant Sciences GmbH • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Spinal cord injury patients get first shot at novel cell delivery device
Disease control Recruiting nowThe DOSED clinical study evaluates the safety and utility of a novel delivery device to deliver LCTOPC1, a cell therapy, to the spinal cord of patients with a spinal cord injury (SCI). LCTOPC1 is designed to replace or support cells that are absent or dysfunctional due to traumat…
Phase 1 • Sponsor: Lineage Cell Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Digital inhaler coach and breathing trainer put to the test against COPD attacks
Disease control Recruiting nowThe goal of this clinical trial is to learn if digital inhaled therapy management (DITM) and inspiratory muscle training (IMT), alone or in combination, can improve outcomes in adults aged 40 years and older with symptomatic, high-risk chronic obstructive pulmonary disease (COPD)…
Sponsor: Sir Run Run Shaw Hospital • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
A prescription app takes on PTSD: can digital therapy replace the couch?
Symptom relief CompletedThis study is exploring the efficacy of a digital therapeutic app in reducing symptoms of posttraumatic stress disorder (PTSD) in adults.
Phase 1 • Sponsor: Oui Therapeutics, Inc. • Aim: Symptom relief
Last updated Jul 29, 2026 00:00 UTC
-
Can a new antibody calm severe eczema?
Disease control CompletedThis study is a multicenter, randomized, double-blind, parallel controlled phase II study. It is planned to include approximately 60 subjects with moderate to severe atopic dermatitis(AD) to evaluate the efficacy and safety of MG-K10 monotherapy in adult patients with moderate to…
Phase 2 • Sponsor: Shanghai Mabgeek Biotech.Co.Ltd • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Can virtual games retrain the brain to restore balance?
Disease control CompletedThis study aims to assess the effectiveness of a motor rehabilitation protocol that includes mixed reality activities, compared to conventional rehabilitation, on postural stability in children and adult patients with neurological impairments.
Sponsor: Slb Pharma • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can augmented reality coach better CPR than a human?
Knowledge-focused Recruiting nowThis study evaluates whether an augmented reality cardiopulmonary resuscitation feedback system (AR-CPR) can support health care providers in delivering high-quality chest compressions during pediatric cardiac arrest. AR-CPR provides real-time visual feedback on chest compression…
Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Aug 28, 2026 00:00 UTC
-
Experimental 'Super-Universal' immune cells take on tough blood cancers
Disease control Recruiting nowThe aim of this study was to evaluate the safety and efficacy of supCD7 CART cells in the treatment of patients with relapsed/refractory CD7-positive hematologic malignancies. In this single-arm, open-label, single-center, Phase Ⅰ+Ⅱ clinical trial, two cohorts were set up: (1) re…
Phase 1/2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Engineered immune cells take on tough blood cancers in early trial
Disease control Recruiting nowThe aim of this study was to evaluate the safety and efficacy of universal CD7 CART (uCD7 CART) cells in the treatment of patients with relapsed/refractory CD7-positive hematologic malignancies. In this single-arm, open-label, single-center, Phase 1 clinical trial, two cohorts we…
Phase 1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 26, 2026 12:55 UTC